Associate Professor 3 at the USP School of Medicine. Head of the Interdisciplinary Neuromodulation Service and Co-Director of the ECT Service of the HC-FMUSP Institute of Psychiatry. Member of the Innovation Committee of HC-FMUSP (INOVAHC). Full Advisor of the PPGs in Medical Sciences and Psychiatry at FMUSP. Appointed by the Web of Science / Clarivate Analytics as one of the most cited researchers in the world in the years 2019, 2020, 2021 and 2022. Prof. Brunoni has more than 365 articles published in indexed journals, with more than 15400 citations and an H index of 57 (Scopus). Prof. Brunoni has publications as 1st or last author in prominent journals such as the New England Journal of Medicine, JAMA Psychiatry, Molecular Psychiatry, Lancet Psychiatry and American Journal of Psychiatry. He has an extensive international network of collaborators, including centers at Harvard University, Oxford University, University of Munich, University of New South Wales, University of Toronto, UTHealth in Texas, Ghent University, and the University of Coimbra. Education: MBA in progress (2021-2022) by USP/Esalq. Habilitation Degree at the Department of Psychiatry at the Faculty of Medicine of USP (2017). Newton Advanced Fellowship, in partnership with Oxford University (2021-2023). Visiting Professor at the University of Munich (April-2017/October-2018) with an experienced researcher grant from CAPES / Alexander Von Humboldt Foundation. PhD in Neuroscience and Behavior at the Institute of Psychology at USP (2010-2012), with a Sandwich Doctorate at Harvard Medical School (Boston, USA). Graduation in Medicine (2004), Residencies in Internal Medicine (2005-2007) and Psychiatry (2007-2010) from the Faculty of Medicine of USP. Lines of investigation: depression and mood disorders, non-invasive neuromodulation in the treatment of mental disorders. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Brazilian science attracting attention worldwide |
| La ciencia brasileña que se ve en el mundo |
| Energy for neurons |
| Energía para las neuronas |
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Major Depressive Disorder (MDD) is a condition with high prevalence and morbidity worldwide. Treatments have limited efficacy and are curbed by adverse effects (Pharmacotherapy) or availability and costs (psychotherapy). Thus, developing novel interventions is tremendously relevant and can bring major gains in psychiatric care. Non-Implantable Neuromodulatory (NIN) approaches such as tran…
Non-invasive brain stimulation approaches have been increasingly used to target the prefrontal cortex and to induce activity changes in brain networks. New protocols within the field of neurostimulation suggest a combination of distinct non-invasive brain stimulation techniques that are based on different approaches to maximize required changes in brain activity. However - as the effects …
Dr. Mantovani will serve as Co-Investigator in our research studies testing the clinical and neurobiological effects of Transcranial Direct Current Stimulation (tDCS) in Major Depressive Disorder (Young Investigator FAPESP grant 2012/20911-5) and Obsessive Compulsive Disorder (ongoing research project at the Institute of Psychiatry). Moreover, Dr. Mantovani will teach graduate and post-gr…
(Only some records are available in English at this moment)
The post-COVID syndrome has become a major health problem due to the extension of the pandemic and the variability of sequelae, generating costs for health systems already overloaded by the pandemic and insecurities regarding the treatment. The lack of knowledge about the pathophysiology of the process and the risk of cognitive decline increase, even more, the concern about this condition…
Major depressive disorder (MDD) causes large decreases in health and quality of life, with increases in health care costs, but the causes and pathogenesis of depression remain largely unknown, which greatly impedes its early detection and effective treatment. With the advancement of neuroimaging approaches, numerous functional and structural changes in the brain were detected in MDD and, …
(Only some records are available in English at this moment)
Countries in the Low-or-Middle-Income Countries (LMIC) group have faced drastic changes in the possibilities of their population's quality of life in recent years. Consequently, there was an increase in life expectancy in these countries, and, consequently, in the prevalence of chronic comorbidities. Thus, there is evidence in the literature of a probable association between these factors…
(Only some records are available in English at this moment)
Major Depressive Disorder (MDD) causes important disabilities. Antidepressant drugs are the MDD most frequent treatment, but other ideal options are needed, and transcranial direct current stimulation (tDCS) is a promising one. TDCS is a non-invasive stimulation technique that injects low-intensity electrical current via electrodes located on the scalp, acting to facilitate or inhibit syn…
| 1 / 1 | Ongoing research grants |
| 4 / 4 | Completed research grants |
| 7 / 7 | Ongoing scholarships in Brazil |
| 31 / 23 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 44 / 36 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID